Automatic drug injection device

The automatic drug injection device addresses the complexity and safety issues of conventional auto-injectors by integrating a simplified structure with an elastic support and trigger module for reliable feedback and needle protection.

WO2026235520A1PCT designated stage Publication Date: 2026-11-12EM TECH CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/KR2026/096730
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-05-08
Filing Date
2026-05-08
Publication Date
2026-11-12

AI Technical Summary

Technical Problem

Conventional auto-injectors lack the ability to determine whether drug injection has started or been completed, and the needle can be exposed externally when the drug is injected, and the needle is not protected from the needle, and the needle is exposed after injection, increasing the risk of injury.

Method used

An automatic drug injection device with a simplified structure that includes a drug container holder with an elastic support portion, a plunger mechanism, and a trigger module for locking and unlocking the plunger, allowing for feedback on injection completion and preventing needle exposure.

Benefits of technology

The device simplifies assembly, reduces the number of parts, provides reliable feedback on injection status, and prevents needle exposure, enhancing user safety and ease of use.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure KR2026096730_12112026_PF_FP_ABST
    Figure KR2026096730_12112026_PF_FP_ABST
Patent Text Reader

Abstract

An embodiment relates to an automatic drug injection device. An embodiment provides an automatic drug injection device comprising: a housing forming the exterior thereof; a drug container comprising a drug storage part for storing a drug and a syringe needle capable of penetrating skin to inject the drug stored in the drug storage part; a drug container holder which fixes the drug container to the housing; a plunger which slides into the drug container and pressurizes the drug; an activation member slidably installed along the housing and having a proximal end protruding out of the housing at an initial position; a first elastic member which presses the activation member in the proximal direction; a second elastic member which presses the plunger in the proximal direction; a trigger housing which locks the plunger when the activation member is in the initial position and is unlocked from the plunger by movement of the activation member; and a trigger module which releases the locking between the plunger and the trigger by the movement of the activation member, wherein the distal end of the drug container has a flange portion extending outward in the radial direction, and the drug container holder includes an elastic support portion which protrudes from the distal end thereof in the distal direction and elastically supports the flange portion.
Need to check novelty before this filing date? Find Prior Art

Description

Automatic drug injector

[0001] The example relates to an automatic drug injection device.

[0002] Self-injectors that allow users to inject themselves without visiting a hospital are widely used for chronic diseases requiring continuous management, such as diabetes, or acute attacks requiring immediate response, such as anaphylactic shock in allergy patients.

[0003] A pen needle-type auto-injector has been developed and is widely used, which can be carried around and inserted into an injection site that meets the conditions, allowing the needle to be automatically inserted into the muscle and the injection fluid to be automatically injected by a device such as a spring.

[0004] However, conventional auto-injectors had the problem that it was impossible to determine whether drug injection had started or been completed. Additionally, there was a disadvantage that the needle of the auto-injector was exposed externally when the device was withdrawn from the user's body after the drug injection was completed.

[0005] To solve these problems, many auto-injectors have been developed that have a structure for locking the injection needle after the injection of the solution is completed, or a feedback structure that can indicate the injection status of the solution.

[0006] Korean Patent No. 10-2059765 discloses a drug infusion device equipped with an automatic feedback mechanism.

[0007] Referring to FIG. 1, a drug delivery device (1) according to the prior art comprises a plunger rod (11) positioned to be biased toward a proximal end (3a), a plunger (13), a first elastic member, i.e., an energy storage member (15), which may be, for example, a spring, positioned to bias the plunger rod (11) in the proximal direction, a second elastic member or energy storage member (9) positioned to bias the drug delivery member cover (7) in the proximal direction, a tubular rotor (17) positioned to accommodate the plunger rod (11) and the first energy storage member (15), a tubular extension member (5) fixed axially and rotationally with respect to a housing (3), a tubular actuating member (17) positioned to accommodate a part of a rear end cap (7) and the plunger rod (11) and referred to as the tubular rotor (17) below, and a first energy storage member (15) positioned to accommodate It further includes a rod (19) and a signal generating member (21) exemplified later as a U-shaped bracket, hereinafter referred to as a "U-bracket." The exemplified drug delivery device (1) further includes a drug container holder (23) and a drug container (25) provided with a needle (25a). A plunger (13) is positioned to travel within the drug container (25) by linear displacement of a plunger rod (11) to release a drug through the needle (25a).

[0008] The plunger rod (11), tubular extension member (5), tubular actuation member (17), energy storage member (15), and signal generating member (21) form an automatic feedback mechanism (12) or simply a feedback mechanism for the drug delivery device (1). The feedback mechanism (12) is positioned to notify the user of the start of drug release from the drug container (25).

[0009] Before use, the plunger rod is fixed axially in its initial position. When the drug delivery device is operated, that is, when the user initiates drug delivery, the plunger rod is released from its initial position and pressurized proximally by the energy storage member. When the plunger rod is displaced by a distance corresponding to the distance required for the initiation of drug release, contact between the first section of the plunger rod and the signal generating member will be interrupted. Accordingly, the plunger rod and the signal generating member are designed such that the axial overlap between the first section of the plunger rod and the signal generating member at the initial position of the plunger rod is equal to or substantially equal to said distance. Thus, the first section supports only the signal generating member during the axial displacement of the plunger rod distance corresponding to the distance required for the initiation of drug release. When the plunger rod is displaced by an amount corresponding to this distance, the signal generating member will bend radially inward without being radially biased. By this, the signal generating member will be separated from the tubular extension member. Therefore, the signal generating member biased in the distal direction by the first energy storage member is no longer maintained by the tubular extension member and will accordingly be thrown toward the distal inner surface of the tubular extension member. This causes a "click" sound to be heard and also provides a tactile sensation to the user.

[0010] However, in the case of conventional automatic drug injection devices, there was a disadvantage in that the number of parts increased and assembly was complex because the operating member for unlocking and operating the plunger rod, the member for locking the drug container holder after the drug injection is finished, and the member for generating feedback were each provided separately.

[0011] Therefore, there is a need to develop an automatic drug injection device that simplifies the structure to reduce the number of parts and facilitates assembly, while also enabling locking and feedback.

[0012] The embodiment aims to provide an automatic drug injection device having an improved drug container support structure.

[0013] An embodiment provides an automatic drug injection device comprising: a housing forming an exterior; a drug container having a drug storage unit for storing a drug and an injection needle capable of injecting the drug stored in the drug storage unit by penetrating the skin; a drug container holder for fixing the drug container to the housing; a plunger for pressurizing a drug sliding into the drug container; an activating member installed to slide along the housing, with a proximal end protruding outside the housing from an initial position; a first elastic member for pressing the activating member in a proximal direction; a second elastic member for pressing the plunger in a proximal direction; a trigger housing that locks the plunger when the activating member is in an initial position and releases the locking with the plunger by the movement of the activating member; and a trigger module that releases the locking between the plunger and the trigger by the movement of the activating member; wherein the distal end of the drug container has a flange portion extending radially outward, and the drug container holder has an elastic support portion that protrudes distally from the distal end and elastically supports the flange portion.

[0014] As another aspect of the embodiment, an automatic drug injection device is provided, characterized in that the drug container holder comprises a body that surrounds the outer circumference of the drug container and a flange portion that extends radially from the distal end of the body, and an elastic support portion is formed on the flange portion.

[0015] As another aspect of the embodiment, an automatic drug injection device is provided, characterized in that the elastic support comprises a pair of legs extending distally at a distance from each other and a bridge connecting the legs.

[0016] As another aspect of the embodiment, an automatic drug injection device is provided, characterized by having a contact projection protruding distally from the center of the bridge.

[0017] As another aspect of the embodiment, an automatic drug injection device is provided, characterized in that the proximal end of the trigger housing has a ring-shaped support end that contacts and supports the flange portion of the drug container.

[0018] As another aspect of the embodiment, an automatic drug injection device is provided, characterized in that the activating member comprises a tubular proximal end, a contact surface formed at the end of the proximal end and in contact with the user's skin, and two or more support ribs protruding from the inner circumference of the proximal end, wherein the proximal end of the first elastic member is supported by the support ribs.

[0019] As another aspect of the embodiment, an automatic drug injection device is provided, characterized by controlling the elastic force of a first elastic member by adjusting the contact position between a support rib and a first elastic member.

[0020] As another aspect of the embodiment, an automatic drug injection device is provided, characterized in that the support rib extends distally from the contact surface, and the contact position of the first elastic member is determined according to the extended length of the support rib.

[0021] As another aspect of the embodiment, an automatic drug injection device is provided, characterized in that the support rib is formed spaced apart from the inner flange, and the contact position of the first elastic member is determined according to the position of the distal end of the support rib.

[0022] The drug injection device provided by the embodiment can mitigate the impact applied to the drug container by supporting the flange portion of the drug container using the elastic support structure of the drug container holder.

[0023] FIG. 1 is a drawing illustrating a drug infusion device according to the prior art.

[0024] FIG. 2 is a perspective view of an automatic drug injection device according to a first embodiment,

[0025] FIG. 3 is an exploded view of an automatic drug injection device according to a first embodiment,

[0026] FIG. 4 is a cross-sectional view of an automatic drug infusion device cut along aa of FIG. 2,

[0027] FIG. 5 is a cross-sectional view of an automatic drug injector cut along bb of FIG. 2,

[0028] FIG. 6 is a perspective view of a drug container holder equipped with an automatic drug injection device according to a first embodiment.

[0029] FIG. 7 is a partial cutaway view illustrating the drug container support of a drug container holder equipped with an automatic drug injection device according to a first embodiment.

[0030] FIG. 8 is a perspective view of a trigger housing equipped with an automatic drug injection device according to a second embodiment,

[0031] FIG. 9 is a partial cutaway view illustrating the drug container support of the trigger housing equipped with an automatic drug injection device according to a second embodiment.

[0032] FIG. 10 is a cross-sectional view illustrating the combination of a first elastic member and an activating member of an automatic drug injection device according to a third embodiment.

[0033] FIG. 11 is a perspective view illustrating an activation member provided by an automatic drug injection device according to a third embodiment.

[0034] Hereinafter, embodiments will be described in more detail with reference to the drawings. However, the concept of the present invention may be embodied in many different forms and should not be limited to the embodiments disclosed herein; rather, these embodiments are provided as examples to ensure that the present disclosure is thorough and complete and sufficiently conveys the scope of the concept of the present invention to those skilled in the art.

[0035] As used herein, the term “proximal end” refers to the end of a drug delivery device where drug release may be provided. Thus, it is the end of the drug delivery device that tapers toward the injection or release site. This definition also extends to any internal or external component of the drug delivery device, that is, the proximal end of any component is the end closest to the proximal end of the drug delivery device. The “distal end” is the end opposite to the proximal end.

[0036] "Proximal direction" refers to the direction along the central axis of the drug delivery device from the distal end toward the proximal end. "Distal direction" refers to the direction opposite to the "proximal direction."

[0037] "Initial position" refers to the location of the parts before use by the user, meaning the position of each part when assembly is completed.

[0038] Furthermore, the term "tube-shaped" refers to having an overall tubular or cylindrical shape, in which slits, holes, grooves, or cuts are formed in parts of the tube or cylinder, or which protrusions, projections, or flange shapes are included.

[0039] FIG. 2 is a perspective view of an automatic drug injection device according to a first embodiment, FIG. 3 is an exploded view of an automatic drug injection device according to a first embodiment, FIG. 4 is a cross-sectional view of an automatic drug injection device cut along aa in FIG. 2, and FIG. 5 is a cross-sectional view of an automatic drug injection device cut along bb in FIG. 2.

[0040] An automatic drug injection device according to the first embodiment has a drug container fixed by a drug container holder (730), the drug container having a drug storage unit (710) for storing a drug within a tubular housing (100) that forms the exterior, and an injection needle (720) capable of injecting the drug stored in the drug storage unit (710) by invading the skin. Within the tubular housing (100), an activating member (200) and a first elastic member (300) for pressing the activating member (200) in a proximal direction are installed on the proximal side of the drug container. The proximal end (210) of the activating member (200) is exposed outside the proximal end of the tubular housing (100) before drug injection and is utilized as a structure to prevent exposure of the needle. If necessary, a proximal cap (140) is attached to the proximal end (210) of the activating member (200), and the proximal end of the proximal cap (140) and the proximal end of the housing (100) come into contact to prevent the activating member (200) from being pressed. A distal cap (120) is installed at the distal end of the housing (100) to close the distal end of the housing (100) after the parts are assembled inside the housing (100).

[0041] On the distal side of the drug container, a plunger (400) that pressurizes the drug and a trigger module (420, 500, 800, 850) that deactivates the plunger (400) and then activates it by the movement of an activation member (200) are installed. In the initial state, the plunger (400) is locked and deactivated by the trigger module (420, 500, 800, 850), and when the trigger of the trigger module (420, 500, 800, 850) is released by the movement of the activation member (200), the plunger (400) is activated and slides within the drug storage unit (710) to pressurize the drug.

[0042] The plunger (400) consists of a plunger rod (410) and a trigger arm (420) extending from the plunger (410) to a distal end, and the trigger arm (420) forms part of a trigger module (420, 500, 800, 850). If necessary, a trigger projection may be provided at the end of the trigger arm (420) to ensure more secure locking.

[0043] The trigger module (420, 500, 800, 850) consists of a trigger housing (500), a trigger arm (420), a safety pin (800) that keeps the trigger housing (500) and the trigger arm (420) locked in place on the trigger housing (500), and a locking pin (850) that prevents the safety pin (800) from coming loose.

[0044] The proximal end of the second elastic member (600) is supported by the plunger (400), and the distal end is supported by the trigger housing (500). The second elastic member (600) is installed in a compressed state so that it can press the plunger (400) in the proximal direction. When the trigger of the trigger module (420, 500, 800, 850) is released, the second elastic member (600) presses the plunger (400) in the proximal direction. At this time, a plunger tube (430) that wraps the second elastic member (600) may be further provided between the second elastic member (600) and the trigger housing (500). The proximal end of the plunger tube (430) is coupled with the plunger rod (410) and moves together with the plunger rod (410). The plunger tube (430) can prevent buckling that may occur during compression and extension of the second elastic member (600). In addition, the outer surface of the plunger tube (430) can also serve to lock the feedback generating element (900) described later.

[0045] The trigger housing (500) according to the first embodiment surrounds the plunger (400) and engages with the plunger arm (420) to restrict the movement of the plunger (400).

[0046] The plunger (400) is locked by the trigger module (420, 500, 800, 850) so that it does not move in the proximal direction even when the pressure of the second elastic member (600) is applied, until the activation member (200) is slid in the distal direction and the trigger of the trigger module is released.

[0047] The proximal end (210) of the activating member (200) is tubular, and the end of the proximal end (210) is provided with a contact surface that contacts the user's skin. A hole is provided in the center of the contact surface, so that when the activating member (200) is retracted, an injection needle (720) is exposed through the hole.

[0048] The activation member (200) further includes an activation arm (220) extending distally from a proximal end (210). When the activation arm (220) moves distally, the activation arm (220) pushes the locking pin (850) distally, and the locking pin (850) pushes the safety pin module (800) distally. When the safety pin module (800) moves distally, the locking of the trigger module (420, 500, 800, 850) is released, and the plunger (400) is activated. The plunger (400) moves within the drug storage unit (710) by receiving a proximal force from the second elastic member (600), and the drug stored in the drug storage unit (710) is injected into the body through the injection needle (720).

[0049] Meanwhile, a feedback generating element (900) that generates a drug termination sound is coupled to the trigger housing (500). The trigger housing (500) is provided with a spring support member (520) that extends radially outward at the proximal end of a tubular trigger body (510). It is also provided with a feedback generating member (540) that extends radially outward at a predetermined distance in the distal direction from the spring support member (520). Additionally, it is provided with a slit (not shown) that extends from the proximal end of the trigger housing (500) through the spring support member (520) toward the feedback generating member (540).

[0050] The feedback generating element (900) is pipe-shaped and contacts the outer surface of the trigger housing (500), and is provided with a flange portion that supports the distal end of the feedback spring (950). In addition, for locking with the trigger housing (500), it is provided with a flexible element (not shown) and a hook (not shown) formed to protrude radially outward from the distal end of the flexible element.

[0051] The trigger housing (500) is provided with a spring support end (520) that extends radially outward near the proximal end. The spring support end (520) supports the proximal end of the feedback spring (950). That is, the proximal end of the feedback spring (950) is supported by the spring support end (520) of the trigger housing (500), and the distal end of the feedback spring (950) is supported by the flange portion (920) of the feedback generating element (900).

[0052] The trigger housing (500) is provided with a slit (not shown) that allows a flexible element (not shown) of the feedback generating element (900) to move inward and outward in the radial direction. The proximal end of the slit (not shown) extends further proximal to the spring support end (520), and the proximal end extends to the proximal end of the trigger housing (500) and is open. Thus, in the initial position, the hook (not shown) of the feedback generating element (900) can pass through the slit (not shown) and be caught on the spring support end (520).

[0053] The distal movement of the feedback spring (950) is restricted by the flange portion (920). When the plunger tube (430) is inserted into the trigger housing (500) and assembled, the flexible element (not shown) of the feedback generating element (900) comes into contact with the outer surface of the plunger tube (430). As the flexible element (not shown) comes into contact with the outer surface of the plunger tube (430), the flexible element (not shown) moves outward in the radial direction. A hook (not shown) formed on the outer side of the proximal end of the flexible element (not shown) interferes with the spring support portion (520) of the trigger housing, thereby locking. When the plunger pipe (430) slides in the proximal direction and the contact between the flexible element (not shown) and the plunger pipe (430) is released, the locking between the feedback generating element (900) and the trigger housing (500) is released.

[0054] FIG. 6 is a perspective view of a drug container holder equipped with an automatic drug injection device according to the first embodiment, and FIG. 7 is a partial cutaway view showing the drug container support of the drug container holder equipped with an automatic drug injection device according to the first embodiment.

[0055] The distal end of the drug container (710; see FIG. 3) is provided with a flange portion (712) that extends radially outward.

[0056] The drug container holder (730) comprises a pipe-shaped body (732) that surrounds the outer circumference of the drug container (710; see FIG. 3) and a flange portion (735) formed at the distal end of the body (732) and extending radially outward. An elastic support portion (734) is formed on the flange portion (735) to elastically support the flange portion (712) of the drug container.

[0057] The pipe-shaped body (732) may be equipped with a flexible hook (732a) or a rib (732b) for joining and fixing to the housing (100).

[0058] The elastic support member (734) is formed on the flange member (735) at a distance in the circumferential direction and comprises a pair of legs (734a) each extending in the distal direction and a bridge (734b) extending in the circumferential direction from the pair of legs (734a) and connecting the pair of legs (734a). The length of the bridge (734b) is longer than the length of the flange member (735) between the pair of legs (734a), so that it can be deformed into a concave or convex shape. Meanwhile, a reinforcing rib (736) may be formed on the proximal side of the flange member (735) to reinforce the rigidity of the flange member (735) supporting the elastic support member (734).

[0059] At this time, a contact projection (734c) protruding in a distal direction may be additionally provided in the center of the bridge (734b). Accordingly, the contact projection (734c) and the flange portion (712) of the drug container (710: see FIG. 3) come into contact, and when an axial impact is applied to the flange portion (712), it is transmitted to the bridge portion (734b) through the contact projection (734c), and the bridge portion (734b) can absorb the impact by elastically deforming.

[0060] Compared to when the bridge portion (734b) is in direct contact with the flange portion (712) without the contact projection (734c), when the contact projection (734c) and the flange portion (712) are in contact, the force is concentrated and transmitted to the contact projection (734c) located in the center of the bridge portion (734b), so the bridge portion (734b) can be deformed much more easily.

[0061] FIG. 8 is a perspective view of a trigger housing equipped with an automatic drug injection device according to a second embodiment.

[0062] The trigger housing (500a) according to the second embodiment is mostly identical in configuration to the trigger housing according to the first embodiment, but differs in that it is provided with a ring-shaped support member (520a) for fixing and supporting a drug container (710) at the proximal end.

[0063] The trigger housing (500) is provided with a ring-shaped support member (520a) at the proximal end of a tubular trigger body (510a). It also has a feedback generating member (540a) that extends radially outward at a predetermined distance in the distal direction from the ring-shaped support member (520a). Additionally, it has a slit (530a) that extends from the distal end of the ring-shaped support member (520a) of the trigger housing (500a) toward the feedback generating member (540a).

[0064] FIG. 9 is a partial cutaway view illustrating the drug container support of the trigger housing equipped with an automatic drug injection device according to a second embodiment.

[0065] The ring-shaped support member (520a) contacts the flange portion (712) of the drug container (710) and prevents the flange portion (712) from moving out of its original position when subjected to impact in the distal direction.

[0066] At this time, the thickness or length of the ring-shaped support member (520a) can be adjusted as needed.

[0067] According to the second embodiment, instead of the outer part of the flange portion (712) of the drug container (710) which has relatively poor durability, the ring-shaped support member (520a) contacts the inner part of the flange portion (712), which is relatively more robust, and the drug container (710) and the flange portion (712) come into contact. Therefore, it is possible to prevent damage caused by the impact being transmitted to the drug container (710) support structure.

[0068] FIG. 10 is a cross-sectional view illustrating the combination of a first elastic member and an activating member of an automatic drug injection device according to a third embodiment, and FIG. 11 is a perspective view illustrating an activating member provided by an automatic drug injection device according to a third embodiment.

[0069] The activating member (200b) is exposed outside the proximal end of the tubular housing (100) before drug injection and includes a tubular proximal end (210b) to which force is applied, and an activating arm (220b) extending distally from the proximal end (210b). The plunger (400; see FIG. 3) is locked by the trigger module (420, 500, 800, 850; see FIG. 3) so that it does not move protly even when pressure from the second elastic member (600; see FIG. 3) is applied until the activating member (200b) slides distally to release the trigger of the trigger module.

[0070] The proximal end (210) of the activating member (200b) is tubular, and the end of the proximal end (210) is provided with a contact surface (212b) that contacts the user's skin. A hole is provided in the center of the contact surface (212b), so that when the activating member (200b) is retracted, the injection needle (720) is exposed through the hole. That is, the contact surface (212b) is in the form of an inner flange extending radially inward from the tubular proximal end (210b) to disperse the pressure applied to the skin upon contact.

[0071] At this time, two or more supporting ribs (214b) are provided protrudingly on the inner surface of the proximal end (210b), and the proximal end of the first elastic member (300) is supported by the supporting ribs.

[0072] At least two support ribs (214b) must be provided to support the first elastic member (300), and preferably provided at symmetrical positions.

[0073] The support rib (214b) may extend distally from the contact surface (212b), or may be formed to extend distally with a gap from the contact surface (212b). By adjusting the contact position between the support rib (214b) and the first elastic member (300), the elastic displacement of the first elastic member (300) can be adjusted, and thus the elastic force of the first elastic member (300) can be adjusted.

[0074] When the support rib (214b) starts from the contact surface (212b), the contact position with the first elastic member (300), i.e., the elastic displacement of the first elastic member (300), is determined by the extended length of the support rib (214b).

[0075] When the support rib (214b) is formed spaced apart from the contact surface (212b), the contact position with the first elastic member (300), i.e., the elastic displacement of the first elastic member (300), is determined according to the end position of the support rib (214b), i.e., the position of the distal end of the support rib (214b). Even if the distance between the support rib (214b) and the contact surface (212b) is large, if the extension length of the support rib (214b) is short, the elastic displacement of the first elastic member (300) may be smaller compared to the case where the distance between the support rib (214b) and the contact surface (212b) is short and the extension length of the support rib (214b) is long.

[0076] According to the third embodiment, there is an advantage in that the amount of compression of the first elastic member (300) and the force applied by the first elastic member (300) can be adjusted simply by changing only the extension length and position of the support rib (214b) without changing the design of the first elastic member (300) in order to change the force applied by the first elastic member (300).

Claims

1. Housing forming the exterior; A drug container having a drug storage unit for storing drugs and a syringe needle capable of injecting the drug stored in the drug storage unit by penetrating the skin; A drug container holder for securing a drug container to a housing; A plunger that pressurizes a drug sliding into a drug container; An activation member installed to slide along a housing, with a proximal end protruding outside the housing from an initial position; A first elastic member that applies pressure to the active member in a proximal direction; A second elastic member that presses the plunger in a proximal direction; A trigger housing that locks the plunger when the activating member is in an initial position, and releases the locking from the plunger by the movement of the activating member; and A trigger module that releases the locking of the plunger and the trigger by the movement of an activation member; is provided, The distal end of the drug container has a flange portion extending radially outward, and An automatic drug injection device characterized by a drug container holder having an elastic support member that protrudes distally from the distal end and elastically supports the flange portion.

2. In Paragraph 1, An automatic drug injection device characterized by a drug container holder having a body that surrounds the outer circumference of a drug container and a flange portion that extends radially from the distal end of the body, and an elastic support portion formed on the flange portion.

3. In Paragraph 2, An automatic drug injection device characterized by an elastic support member having a pair of legs extending distally at a distance from each other and a bridge connecting the legs.

4. In Paragraph 3, An automatic drug injection device characterized by having a contact projection protruding distally from the center of the bridge.

5. In Paragraph 1, An automatic drug injection device characterized in that the proximal end of the trigger housing is provided with a ring-shaped support portion that contacts and supports the flange portion of a drug container.

6. In Paragraph 1, The activating member comprises a tubular proximal end, a contact surface formed at the distal end of the proximal end and in contact with the user's skin, and two or more support ribs protruding from the inner circumference of the proximal end. An automatic drug injection device characterized in that the proximal end of a first elastic member is supported by a support rib.

7. In Paragraph 6, An automatic drug injection device characterized by controlling the elastic force of a first elastic member by adjusting the contact position between a support rib and a first elastic member.

8. In Paragraph 7, The support rib extends distally from the contact surface, and An automatic drug injection device characterized in that the contact position of the first elastic member is determined according to the extended length of the support rib.

9. In Paragraph 7, The support rib is formed spaced apart from the inner flange, and An automatic drug injection device characterized in that the contact position of the first elastic member is determined according to the position of the distal end of the support rib.